Skip to main content
. 2014 May 22;14:487. doi: 10.1186/1471-2458-14-487

Table 2.

Quantitative variables of the subjects as a function of the diagnosis of premorbid metabolic syndrome based on the WHO proposal

  Total n = 621 Pre-MetS n = 136 Non Pre-MetS n = 485 p
Age (years)
48.5 (SD = 12.4)
54.5 (SD = 9.2)
46.8 (SD = 12.7)
<0.001
Waist C (cm)
92.0 (SD = 13.6)
103.3 (SD = 11.8)
88.8 (SD = 12.3)
<0.001
BMI (kg/m2)
26.3 (SD = 4.5)
29.8 (SD = 4.6)
25.3 (SD = 3.9)
<0.001
Fasting glucose(mg/dl)
93.7 (SD = 14.3)
105.5 (SD = 17.9)
90.3 (SD = 10.9)
<0.001
Total cholesterol (mg/dl)
205.3 (SD = 39.9)
219.5 (SD = 41.1)
201.4 (SD = 38.7)
<0.001
HDL-cholesterol (mg/dl)
58.8 (SD = 14.7)
49.2 (SD = 13.4)
61.5 (SD = 14.0)
<0.001
Triglyceride (mg/dl)
122.7 (SD = 83.4)
189.3 (SD = 132.7)
103.8 (SD = 48.8)
<0.001
SBP (mm Hg)
126.8 (SD = 16.2)
138.3 (SD = 15.5)
123.6 (SD = 14.9)
<0.001
DBP (mm Hg)
77.0 (SD = 10.4)
82.7 (SD = 10.7)
75.4 (SD = 9.6)
<0.001
CVR (Score)
1.5 (SD = 1.9)
2.5 (SD = 2.3)
1.2 (SD = 1.5)
<0.001
CVR (Regicor) 3.3 (SD = 2.3) 4.8 (SD = 2.6) 2.8 (SD = 1.9) <0.001

p ≤ 0.05 is considered to be statistically significant.

Data are expressed as means (Standard Deviation).

Pre-MetS premorbid metabolic syndrome; BMI body mass index; SBP systolic blood pressure; DBP diastolic blood pressure; CVR cardiovascular risk.